FDA Approved Products

Application #	Type	Sponsor	Product #	Drug Name	Form	Strength	Active Ingredient	Approval Date	Marketing Status	Reference Standard
761312	BLA	CITIUS PHARMS	001	LYMPHIR	INJECTABLE;INJECTION	300MCG	DENILEUKIN DIFTITOX-CXDL	2024-08-07	Prescription	No
202088	NDA	CITIUS PHARMS	001	SUPRENZA	TABLET, ORALLY DISINTEGRATING;ORAL	15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	PHENTERMINE HYDROCHLORIDE	2011-06-13	Discontinued	No
			002	SUPRENZA	TABLET, ORALLY DISINTEGRATING;ORAL	30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	PHENTERMINE HYDROCHLORIDE	2011-06-13	Discontinued	No
			003	SUPRENZA	TABLET, ORALLY DISINTEGRATING;ORAL	37.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	PHENTERMINE HYDROCHLORIDE	2011-06-13	Discontinued	No